Contraceptive use and subsequent fertility.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000023:Abortion Applicants; D000026:Abortion, Habitual / Q000139:chemically induced; D000029:Abortion, Legal; D000032:Abortion, Therapeutic; D000568:Amenorrhea / Q000139:chemically induced; D002869:Chromosome Aberrations / Q000139:chemically induced; D025063:Chromosome Disorders; D003267:Contraception / Q000009:adverse effects; D003274:Contraceptive Devices, Female; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects; D003280:Contraceptives, Oral, Synthetic / Q000494:pharmacology; D004314:Down Syndrome / Q000139:chemically induced; D005260:Female; D005298:Fertility / Q000187:drug effects; D005333:Fetus / Q000187:drug effects; D006801:Humans; D007434:Intrauterine Devices / Q000009:adverse effects; D008599:Menstruation Disturbances / Q000139:chemically induced; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011372:Progestins / Q000009:adverse effects; D013577:Syndrome; D014481:United States
D003278:Contraceptives, Oral, Hormonal; D003280:Contraceptives, Oral, Synthetic; D011372:Progestins